Quantcast

Reportlinker Adds The Market for Heart Benefit Foods (3rd Edition)

November 23, 2009

NEW YORK, Nov. 23 /PRNewswire/ — Reportlinker.com announces that a new market research report is available in its catalogue.

The Market for Heart Benefit Foods (3rd Edition)

http://www.reportlinker.com/p0165300/The-Market-for-Heart-Benefit-Foods-(3rd-Edition).html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire

The global functional foods market continues to develop at a fast pace with growth outstripping that of conventional foods, and product innovation rife. The EU Nutrition and Health Claims Directive’s strict approach to health claims however will clearly influence the future development of the sector, and heightens the need for the latest intelligence. Heart health continues to attract the highest attention of food manufacturers and ingredients suppliers worldwide with cholesterol-lowering and omega-3 fortified foods being two of the more established functional foods sectors globally. This report covers developments in the US, Japan, Australia and Europe, including latest market data and key market drivers, product trends, the regulatory environment, ingredients and patents, and future prospects.

1. INTRODUCTION

2. EXECUTIVE SUMMARY

2.1 Market Size and Segmentation

2.2 Key Market Drivers

2.3 Innovation and New Product Development

2.4 The Regulatory Environment

2.5 Industry Dynamics

2.6 Future Prospects

3. MARKET SITUATION

3.1 Overview

3.2 Cereal Products

3.2.1 Overview

3.2.2 Europe

3.2.4 Japan

3.2.5 Australia

3.3 Fats and Oils

3.3.1 Overview

3.3.2 Europe

3.3.3 US

3.3.4 Japan

3.3.5 Australia

3.4 Fish and Eggs

3.4.1 Overview

3.4.2 Europe

3.4.3 US

3.4.4 Japan

3.4.5 Australia

3.5 Bakery Products

3.5.1 Overview

3.5.2 Europe

3.5.3 US

3.5.4 Japan

3.5.5 Australia

3.6 Soya Products

3.6.1 Overview

3.6.2 Europe

3.6.3 US

3.6.4 Japan

3.6.5 Australia

3.7 Dairy Products

3.7.1 Overview

3.7.2 Europe

3.7.3 US

3.7.4 Japan

3.7.5 Australia

3.8 Soft Drinks

3.8.1 Overview

3.8.2 Europe

3.8.3 US

3.8.4 Japan

3.8.5 Australia

3.9 Confectionery

3.9.1 Overview

3.9.2 Europe

3.9.3 US

3.9.4 Japan

3.9.5 Australia

4. PRODUCT TRENDS

4.1 Overview

4.1.1 Europe

4.1.2 US

4.1.3 Japan

4.1.4 Australia

4.2 Cholesterol-lowering Foods and Drinks

4.2.1 Phytosterols/phytostanols

4.2.2 Wholegrains

4.2.3 Oat bran/betaglucan

4.2.4 Soya protein

4.2.5 Psyllium

4.3 Circulatory Health Foods and Drinks

4.3.1 Omega-3/DHA

4.4 Anti-Hypertensive Food and Drinks

4.4.1 Bioactive peptides

4.4.2 Potassium

4.5 Antioxidant Heart Health Foods and Drinks

5. REGULATORY OVERVIEW

5.1 EU

5.1.1 Novel foods

5.1.2 Specific labelling requirements for plant sterols enriched foods

5.1.3 Health Claims

5.2 US

5.2.1 NLEA Authorized Health Claims

5.2.2 Health Claims Based on Authoritative Statements

5.2.3 Qualified Health Claims

5.3 Japan

5.3.1 Introduction

5.3.2 Food with Nutrition Function Claims (FNFC)

5.3.3 Foods for Specified Health Uses (FOSHU)

5.3.4 Other Health food

5.3.5 Novel Food

5.4 Australia

5.4.1 Claims

5.4.2 Novel foods

5.4.3 Food supplement

6. HEART AND CIRCULATORY DISEASE

6.1 Summary

6.2 Prevalence by Country and Trends in Incidence

6.2.1 Variation in circulatory disease death rates across countries

6.2.2 Influence of gender and age on death rates from circulatory diseases 154

6.2.3 Variation in hypertensive disease death rates across countries

6.2.4 Death rates from cerebrovascular disease

6.3 Background to Cardiovascular Disease (CVD)

6.3.1 Atherosclerosis

6.3.2 Thrombosis

6.4 Risk Factors

6.4.1 Types of evidence

6.4.2 Categories of risk factors for CHD

6.4.3 Irreversible risk factors

6.4.4 Potentially Reversible Factors – Physiological

6.4.5 Lifestyle

6.4.6 Psychosocial Factors

6.4.7 Early development

6.4.8 Medical conditions that increase risk of CHD

6.4.9 Prevention

6.5 References

6.6 Further Reading

7. EFFECT OF DIET: CURRENT AND POTENTIAL HEART- HEALTH INGREDIENTS

7.1 Summary

7.2 Principal Heart Health Dietary Factors

7.2.1 Soya

7.2.2 Unsaturated fatty acids

7.2.3 Plant Sterol and Stanols

7.2.4 Dietary fibre

7.2.5 Antioxidant vitamins E and C

7.2.6 Folic acid

7.2.7 Potassium-based salt replacers

7.3 Other Up-and-coming Heart Health Ingredients

7.3.1 Carotenoids

7.3.2 Vitamins B6, B12 and B3

7.3.3 Vitamin D

7.3.4 Garlic

7.3.5 Antioxidant polyphenols and flavonoids

7.3.6 L-arginine

7.3.7 Magnesium

7.3.8 Bioactive peptides

7.3.9 Chitosan

7.3.10 Wholegrains

7.4 Less Well-proven Ingredients

7.4.1 Conjugated linoleic acid

7.4.2 Plant lignans

7.4.3 Rice bran oil (contains sterols, tocotrienols, gamma-oryzanol)

7.4.4 Coenzyme Q10

7.4.5 Betaine

7.4.6 Selenium

7.5 References

7.6 Further Reading

8. PATENT REVIEW

8.1 Summary

8.2 Cholesterol-lowering Products

8.2.1 Phytosterols and phytostanols

8.2.2 Cholesterol-lowering soya protein products

8.2.3 Soluble fibre

8.3 Circulatory Health

8.3.1 PUFA-containing products

8.4 Anti-hypertensives

8.4.1 Anti-hypertensive compositions

8.4.2 Anti-hypertensive bioactive peptides

8.5 Multiple-benefit and Miscellaneous Heart-health Products

8.6. Polyphenols and Flavonoids

9. HEART HEALTH INGREDIENTS – PROPERTIES AND AVAILABILITY

9.1 Ingredients (A-Z)

9.1.1 Antioxidant vitamins (vitamins C and E, and coenzyme Q10)

9.1.2 Antioxidant polyphenols and flavonoids

9.1.3 Arginine

9.1.4 B vitamins (vitamins B3, B6 and B12)

9.1.5 a-glucan – See Dietary fibre

9.1.6 Betaine

9.1.7 Bioactive peptides

9.1.8 Carotenoids

9.1.9 Chitosan

9.1.10 Coenzyme Q10 – See Antioxidant vitamins

9.1.11 Conjugated linoleic acid

9.1.12 Dietary fibre

9.1.13 Fibre – See Dietary fibre

9.1.14 Flaxseed

9.1.15 Folic acid

9.1.16 Garlic

9.1.17 Isoflavones – See Soya

9.1.18 Lactic acid bacteria

9.1.19 Linseed – See Flaxseed

9.1.20 Magnesium

9.1.21 Monounsaturated fatty acids (MUFAs)

9.1.22 Mushroom nutraceuticals (see also Chitosan)

9.1.23 Omega-3 polyunsaturated fatty acids (n-3 PUFAs)

9.1.24 Phytochemicals – See Antioxidant polyphenols and flavonoids

9.1.25 Phytosterol and phytostanol esters

9.1.26 Psyllium – See Dietary fibre

9.1.27 Rice bran oil

9.1.28 Salt substitutes

9.1.29 Saponins

9.1.30 Soya

9.1.31 Vitamin D

9.1.32 Tocotrienols – See Antioxidant vitamins and Rice bran oil

9.1.33 Vitamins – See Antioxidant vitamins, B vitamins and Folic acid

9.1.34 Ubiquinone – See Antioxidant vitamins

9.1.35 Wholegrains – See Dietary fibre

LIST OF TABLES

TABLE 2.I Heart Benefit Foods Market Development, 2009-2014

TABLE 2.II Heart Benefit Cereal Products: Global Market Prospects Summary

TABLE 2.III Heart Benefit Fats and Oils: Global Market Prospects Summary

TABLE 2.IV Heart Benefit Fish and Eggs: Global Market Prospects Summary

TABLE 2.V Heart Benefit Bakery Products: Global Market Prospects Summary

TABLE 2.VI Heart Benefit Soya Products: Global Market Prospects Summary

TABLE 2.VII Heart Benefit Dairy Products: Global Market Prospects Summary

TABLE 2.VIII Heart Benefit Soft Drinks: Global Market Prospects Summary

TABLE 2.IX Heart Benefit Confectionery: Global Market Prospects Summary

TABLE 3.I Heart Benefit Foods – Market Trends by Country, 2009

TABLE 3.II Heart Benefit Foods – Market Trends by Type of Product, 2009

TABLE 3.III Heart Benefit Cereal Products – Market Trends by Country, 2009

TABLE 3.IV Heart Benefit Fats and Oils – Market Trends by Country, 2009

TABLE 3.V Phytosterol/Phytostanol Spreads – Key Brands, 2009

TABLE 3.VI Omega-3/Polyunsaturated Heart Health Spreads – Key Brands, 2009 .43

TABLE 3.VII France: Anti-cholesterol Margarine Market by Volume and Value,2005- 2009

TABLE 3.VIII UK: Cholesterol-Lowering Spreads Market by Value, 2005-2009

TABLE 3.IX Australia: Cholesterol-lowering Margarine Market by Volume and Value, 2005-09

TABLE 3.X Heart Benefit Fish and Eggs – Market Trends by Country, 2009

TABLE 3.XI Heart Benefit Bakery Products – Market Trends by Country, 2009

TABLE 3.XII Heart Benefit Soya Products – Market Trends by Country, 2009

TABLE 3.XIII Heart Benefit Dairy Products – Market Trends by Country, 2009

TABLE 3.XIV Heart Health Active Health Drinks – Key Brands, 2009

TABLE 3.XV Spain: Heart Benefit Dairy Products Market by Type, 2008-2009

TABLE 3.XVI Spain: Active Health Drinks Market by Type, 2004-2008

TABLE 3.XVII Spain: Anti-Cholesterol Drinks Market by Value, 2004-2009

TABLE 3.XVIII Spain: Heart Milks Market by Volume and Value, 2006-2009

TABLE 3.XIX Spain: Heart Health Milks Market Shares, 2008

TABLE 3.XX UK: Heart Benefit Dairy Products Market by Type, 2008-2009

TABLE 3.XXI UK: Functional and Cholesterol-Lowering Yoghurt Markets, 2005-2009

TABLE 3.XXII UK: Active Health and Cholesterol-Lowering Drinks Markets, 2005- 2009

TABLE 3.XXIII Heart Benefit Soft Drinks – Market Trends by Country, 2009

TABLE 3.XXIV Heart Benefit Confectionery – Market Trends by Country, 2009

TABLE 4.I Cholesterol-lowering Foods and Drinks: New Product Activity, 2007-2009

TABLE 4.II Circulatory Health Foods and Drinks: New Product Activity, 2007-2009

TABLE 4.III Anti-Hypertensive Foods and Drinks: New Product Activity, 2007-2009

TABLE 4.IV Antioxidant Heart Health Foods and Drinks: New Product Activity, 2007- 2009

TABLE 6.I Number of Registered Death Rates for all Causes of Death and Deaths by Diseases of the Circulatory System per 100,000 Population by Country, Year and Sex

TABLE 6.II Number of Registered Death Rates from Diseases of the Circulatory System per 100,000 UK Population, by Age Group and Sex, 2006

TABLE 6.III Number of Registered Death Rates from Hypertensive Disease per 100,000 Population by Country, Year and Sex

TABLE 6.IV Number of Registered Death Rates from Cerebrovascular Disease per 100,000 Population by Country, Year and Sex

TABLE 6.V Number of Registered Death Rates from Cerebrovascular Disease per 100,000 Population by Country, Year and Sex

TABLE 6.VI Study Methods to Determine Risk and Causal Factors

TABLE 6.VII Risk Factors for Coronary Heart Disease

TABLE 6.VIII Genetic Disorders Relevant to CHD

TABLE 6.IX Blood Pressure Categories

TABLE 6.X Classification of Plasma Lipoproteins

TABLE 6.XI Relationship Between Blood Cholesterol Level and Risk of Coronary Heart Disease

TABLE 6.XII Examples of Antioxidant Defences

TABLE 6.XIII Summary of the Interrelation Between Diet and Physiological Risk Factors for Coronary Heart Disease

TABLE 6.XIV Principles of Prevention Strategies for Coronary Heart Disease

TABLE 6.XV Dietary Recommendations (Population Averages) for the Prevention of Coronary Heart Disease

TABLE 7.I Beneficial Effects of the n-3 Fatty Acids: EPA and DHA

TABLE 8.I Other Patents Relating to Phytostanols and Phytosterols

TABLE 8.II Other Patents Relating to Cholesterol-lowering Soya Products

Table 8.III Other Patents Relating to Cholesterol-lowering Soluble Fibre

TABLE 8.IV Other Patents Relating to Polyunsaturated Fatty Acids

TABLE 8.V Other Patents Relating to Anti-hypertensives

TABLE 8.VI Other Patents Relating to Bioactive Anti-hypertensive Peptides

TABLE 8.VII Other Patents Relating to Miscellaneous Heart-health Products

TABLE 8.VIII Other Patents Relating to Polyphenols and Flavonoids

LIST OF FIGURES

Figure 1 Heart Benefit Foods Market by Country, 2009

Figure 2 Heart Benefit Foods Market by Product Type, 2009

Figure 3 Plaque Formation

Figure 4 Processes Involved in Blood Clotting

Figure 5 Production of Homocysteine

To order this report:

The Market for Heart Benefit Foods (3rd Edition)

http://www.reportlinker.com/p0165300/The-Market-for-Heart-Benefit-Foods-(3rd-Edition).html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire

More market research reports here!


Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker


Source: newswire



comments powered by Disqus